Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury

Journal of the American Society of Nephrology

Volumn 25, Issue 12, 2014, Pages 2847-2858

  Chen, Yi Ting ^a,b,c   Chang, Yu Ting ^a   Pan, Szu Yu ^b   Chou, Yu Hsiang ^a,b   Chang, Fan Chi ^a,b   Yeh, Pei Ying ^a   Liu, Yuan Hung ^d   Chiang, Wen Chih ^b   Chen, Yung Ming ^b   Wu, Kwan Dun ^b   Tsai, Tun Jun ^b   Duffield, Jeremy S ^e   Lin, Shuei Liong ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; IMATINIB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; COLLAGEN TYPE I, ALPHA 1 CHAIN; GENETIC MARKER; GREEN FLUORESCENT PROTEIN; HYPOCHLOROUS ACID; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1;

ABDOMINAL INJURY; ANIMAL EXPERIMENT; ARTICLE; CELL FATE; CELL LINEAGE; CELL POPULATION; CELL REGENERATION; FIBROBLAST; GENE MAPPING; IN VITRO STUDY; MEMBRANE DAMAGE; MESOTHELIUM CELL; MOUSE; NONHUMAN; PERITONEAL FIBROSIS; PERITONEAL INJURY; PRIORITY JOURNAL; SUBMESOTHELIAL FIBROBLAST; ANIMAL; C57BL MOUSE; CHEMISTRY; EPITHELIUM; EPITHELIUM CELL; FIBROSIS; GENETIC MARKER; GENETICS; METABOLISM; PATHOLOGY; PERITONEUM; REPORTER GENE; TRANSGENIC MOUSE;

ANIMALS; CELL LINEAGE; COLLAGEN TYPE I; EPITHELIAL CELLS; EPITHELIUM; FIBROBLASTS; FIBROSIS; GENES, REPORTER; GENETIC MARKERS; GREEN FLUORESCENT PROTEINS; HYPOCHLOROUS ACID; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERITONEAL FIBROSIS; PERITONEUM; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84923861810     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013101079     Document Type: Article

References (50)

1. Grassmann A, Gioberge S, Moeller S, Brown G: ESRD patients in 2004: Global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 20: 2587-2593, 2005
2. Wu MS, Wu IW, Shih CP, Hsu KH: Establishing a platform for battling end-stage renal disease and continuing quality improvement in dialysis therapy in Taiwan - Taiwan Renal Registry Data System (TWRDS). Acta Nephrol 25: 148-153, 2011
3. Kramer A, Stel VS, Abad Diez JM, Alonso de la Torre R, Bouzas Caamaño E, Čala S, Cao Baduell H, Castro de la Nuez P, Cernevskis H, Collart F, Couchoud C, de Meester J, Djukanovic L, Ferrer-Alamar M, Finne P, Fogarty D, de los Ángeles García Bazaga M, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R, Leivestad T, Limido A, Lopot F, Macario F, Magaz Å, Martín-Escobar E, Metcalfe W, Noordzij M, Ots-Rosenberg M, Palsson R, Piñera C, Postorino M, Prutz KG, Ratkovic M, Resic H, Rodríguez Hernández A, Rutkowski B, Serdengec¸ti K, Yebenes TS, Spustová V, Stojceva-Taneva O, Tomilina NA, van de Luijtgaarden MWM, van Stralen KJ,Wanner C, Jager KJ: Renal replacement therapy in Europe-a summary of the 2010 ERA-EDTA Registry Annual Report. Clin Kidney J 6: 105-115, 2013
4. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, Krediet RT: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19: 517-525, 1999
5. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT; Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479, 2002
6. Korte MR, Sampimon DE, Betjes MGH, Krediet RT: Encapsulating peritoneal sclerosis: The state of affairs. Nat Rev Nephrol 7: 528-538, 2011
7. Chang FC, Huang TM, Li WY, Lin SL: Café-au-lait ascites in encapsulating peritoneal sclerosis. Kidney Int 79: 1261, 2011
8. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA, Kelly MM: Transient overexpression of TGF-β1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16: 425-436, 2005
9. Devuyst O, Margetts PJ, Topley N: The pathophysiology of the peritoneal membrane. J AmSoc Nephrol 21: 1077-1085, 2010
10. Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sánchez-Tomero JA, Jiménez-Heffernan JA, López-Cabrera M: Mesenchymal conversion of mesothelial cells as amechanism responsible for high solute transport rate in peritoneal dialysis: Role of vascular endothelial growth factor. Am J Kidney Dis 46: 938-948, 2005
11. Michailova KN: A combined electron microscopic investigation of the peritoneal mesothelium in the rat. Eur J Morphol 33: 265-277, 1995
12. Asahina K, Tsai SY, Li P, IshiiM, Maxson RE Jr, Sucov HM, Tsukamoto H: Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development. Hepatology 49: 998-1011, 2009
13. Asahina K, Zhou B, PuWT, Tsukamoto H: Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology 53: 983-995, 2011
14. Colmont CS, Raby A-C, Dioszeghy V, Lebouder E, Foster TL, Jones SA, Labéta MO, Fielding CA, Topley N: Human peritonealmesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors. Nephrol Dial Transplant 26: 4079-4090, 2011
15. Amenta PS, Harrison D: Expression and potential role of the extracellular matrix in hepatic ontogenesis: A review. Microsc Res Tech 39: 372-386, 1997
16. TopleyN, Jörres A, LuttmannW, PetersenMM, LangMJ, Thierauch KH, Müller C, Coles GA, Davies M, Williams JD: Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1 beta and TNF alpha. Kidney Int 43: 226-233, 1993
17. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klingler P, Grage B, Schmahl M, Knabbe C: Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 148: 1679-1688, 1996
18. Patel P, West-Mays J, Kolb M, Rodrigues JC, Hoff CM, Margetts PJ: Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells. Matrix Biol 29: 97-106, 2010
19. Liu L, Shi CX, Ghayur A, Zhang C, Su JY, Hoff CM, Margetts PJ: Prolonged peritoneal gene expression using a helper-dependent adenovirus. Perit Dial Int 29: 508-516, 2009
20. Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson EW, Harris CC: Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res 47: 6180-6184, 1987
21. Onitsuka I, Tanaka M, Miyajima A: Characterization and functional analyses of hepatic mesothelial cells in mouse liver development. Gastroenterology 138: 1525-1535, e1- e6, 2010
22. Sakai N, Chun J, Duf field JS, Wada T, Luster AD, Tager AM: LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation. FASEB J 27: 1830-1846, 2013
23. Beavis MJ, Williams JD, Hoppe J, Topley N: Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis ef fluent. Kidney Int 51: 205-215, 1997
24. Fang CC, Lai MN, Chien CT, Hung KY, Tsai CC, Tsai TJ, Hsieh BS: Effects of pentoxifylline on peritoneal fibroblasts and silica-induced peritoneal fi brosis. Perit Dial Int 23: 228-236, 2003
25. Yang AH, Chen JY, Lin JK: Myofibroblastic conversion of mesothelial cells. Kidney Int 63: 1530-1539, 2003
26. Yáñez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, Aguilera A, Sánchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sánchez-Madrid F, López-CabreraM: Peritoneal dialysis and epithelial-to-mesenchymal transition ofmesothelial cells. NEngl JMed 348: 403-413, 2003
27. Bajo MA, Pérez-Lozano ML, Albar-Vizcaino P, del Peso G, Castro M-J, Gonzalez-Mateo G, Fernández-Perpén A, Aguilera A, Sánchez-Villanueva R, Sánchez-Tomero JA, López-Cabrera M, Peter ME, Passlick-Deetjen J, Selgas R: Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fl uid. Nephrol Dial Transplant 26: 282-291, 2011
28. Wong TYH, Phillips AO, Witowski J, Topley N: Glucose-mediated induction of TGF-β 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 63: 1404-1416, 2003
29. Li Y, Wang J, Asahina K: Mesothelial cells give rise to hepatic stellate cells and myofibroblasts viamesothelial-mesenchymal transition in liver injury. Proc Natl Acad Sci U S A 110: 2324-2329, 2013
30. Walker C, Rutten F, Yuan X, Pass H, Mew DM, Everitt J: Wilms' tumor suppressor gene expression in rat and human mesothelioma. Cancer Res 54: 3101-3106, 1994
31. Chau Y-Y, Brownstein D, Mjoseng H, Lee W-C, Buza-Vidas N, Nerlov C, Jacobsen SE, Perry P, Berry R, Thornburn A, Sexton D, Morton N, Hohenstein P, Freyer E, Samuel K, van 't Hof R, Hastie N: Acute multiple organ failure in adult mice deleted for the developmental regulator Wt1. PLoS Genet 7: e1002404, 2011
32. Parenti R, Perris R, Vecchio GM, Salvatorelli L, Torrisi A, Gravina L, Magro G: Immunohistochemical expression of Wilms' tumor protein (WT1) in developing human epithelial and mesenchymal tissues. Acta Histochem 115: 70-75, 2013
33. Levine S, Saltzman A: Abdominal cocoon: An animal model for a complication of peritoneal dialysis. Perit Dial Int 16: 613-616, 1996
34. Huang JW, Yen CJ, Wu HY, Chiang CK, Cheng HT, Lien YC, Hung KY, Tsai TJ: Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis. Blood Purif 31: 252-258, 2011
35. Kitamura M, Nishino T, Obata Y, Furusu A, Hishikawa Y, Koji T, Kohno S: Epigallocatechin gallate suppresses peritoneal fibrosis in mice. Chem Biol Interact 195: 95-104, 2012
36. Margetts PJ, Hoff C, Liu L, Korstanje R, Walkin L, Summers A, Herrick S, Brenchley P: Transforming growth factor b-induced peritoneal fibrosis is mouse strain dependent. Nephrol Dial Transplant 28: 2015-2027, 2013
37. Lin SL, Kisseleva T, Brenner DA, Duf field JS: Pericytes and perivascular fi broblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173: 1617-1627, 2008
38. Humphreys BD, Lin SL, Kobayashi A, Hudson TE,Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176: 85-97, 2010
39. Koesters R, Kaissling B, Lehir M, Picard N, Theilig F, Gebhardt R, Glick AB, Hähnel B, Hosser H, Gröne HJ, Kriz W: Tubular overexpression of transforming growth factor-beta1 induces autophagy and fi brosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 177: 632-643, 2010
40. Asada N, Takase M, Nakamura J, Oguchi A, Asada M, Suzuki N, Yamamura K, Nagoshi N, Shibata S, Rao TN, Fehling HJ, Fukatsu A, Minegishi N, Kita T, Kimura T, Okano H, Yamamoto M, Yanagita M: Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 121: 3981-3990, 2011
41. Göritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisén J: A pericyte origin of spinal cord scar tissue. Science 333: 238-242, 2011
42. Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J, Noble PW, Hogan BL: Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A 108: E1475-E1483, 2011
43. Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C, Iwaisako K, Moore-Morris T, Scott B, Tsukamoto H, Evans SM, Dillmann W, Glass CK, Brenner DA: Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A 109: 9448-9453, 2012
44. Dulauroy S, Di Carlo SE, Langa F, Eberl G, Peduto L: Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. NatMed 18: 1262-1270, 2012
45. Chen YT, Chang FC, Wu CF, Chou YH, Hsu HL, Chiang WC, Shen J, Chen YM, Wu KD, Tsai TJ, Duf field JS, Lin SL: Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 80: 1170-1181, 2011
46. Hung C, Linn G, Chow Y-H, Kobayashi A, Mittelsteadt K, Altemeier WA, Gharib SA, Schnapp LM, Duffield JS: Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 188: 820-830, 2013
47. Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS,McMahon AP, Bonventre JV: Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2: 284-291, 2008
48. Zheng B, Zhang Z, Black CM, de Crombrugghe B, Denton CP: Ligand-dependent genetic recombination in fibroblasts:Apotentially powerful technique for investigating gene function in fi brosis. Am J Pathol 160: 1609-1617, 2002
49. Zhou B,MaQ, Rajagopal S, Wu SM, Domian I, Rivera-Feliciano J, Jiang D, von Gise A, Ikeda S, Chien KR, Pu WT: Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454: 109-113, 2008
50. Wu CF, Chiang WC, Lai CF, Chang FC, Chen YT, Chou YH, Wu TH, Linn GR, Ling H, Wu KD, Tsai TJ, Chen YM, Duffield JS, Lin SL: Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. Am J Pathol 182: 118-131, 2013